Erectile Dysfunction Completed Phase 2 Trials for Sildenafil (DB00203)

Also known as: EDS / ED / Erectile difficulties / Erectile Dysfunction (ED) / Difficulty maintaining an erection / Decreased erections / Male Erectile Disorder / Male Erectile Dysfunction / Difficult erection / Inability to achieve or maintain erection / Erectile Dysfunctions / Male erectile dysfunction, unspecified / Erectile dysfunction (disorder) / Impotence / Erectile dysfunction NOS / Impotent / Erectile disturbance / Erection failure / Psychogenic impotence

IndicationStatusPhase
DBCOND0029956 (Erectile Dysfunction)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02390960Phase 2a Topical Sildenafil Proof-of-Concept Study in Men With Mild to Moderate EDTreatment
NCT00914277SAR407899 Single-dose in Treatment of Mild to Moderate Erectile DysfunctionTreatment
NCT00862888Study to Investigate Effect of a New Drug (PF-00446687) in Males Suffering From Erectile DysfunctionTreatment